Literature DB >> 22419375

Chronic kidney disease and the risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents.

Yu Miao1, Zhou Yu-Jie, Wang Zhi-Jian, Shi Dong-Mei, Liu Yu-Yang, Zhao Ying-Xin, Gao Fei, Yang Shi-Wei, Jia De-An.   

Abstract

BACKGROUND: Chronic kidney disease (CKD) has been demonstrated to be associated with adverse clinical outcomes for patients with coronary artery disease (CAD). However, data on relation of CKD and stent thrombosis (ST) after drug-eluting stent (DES) implantation are limited.
OBJECTIVES: This study was designed to examine whether CKD is associated with higher incidence of ST after elective coronary DES implantation compared with patients with normal renal function.
METHODS: We consecutively enrolled 2,862 patients undergoing elective percutaneous coronary intervention (PCI) with DES. Demographic and clinical data were collected preoperatively. CKD was defined as estimated glomerular filtration rate (eGFR) < 60 ml/min, calculated using the modified MDRD equation. The primary outcome was 1-year definite or probable ST.
RESULTS: Four hundred and forty-five participants (15.5%) had CKD before procedure. The incidence of 1-year definite or probable ST was significantly higher in CKD patients compared with patients with normal renal function (1.8% vs. 0.6%, P = 0.014). After adjustment for multiple clinical and biochemical covariates, CKD was an independent predictor of 1-year definite or probable ST (hazard rate [HR] 0.396, 95% CI 0.165-0.951, P = 0.038).
CONCLUSION: CKD is significantly associated with increased incidence of 1-year definite or probable ST in patients undergoing PCI with DES.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22419375     DOI: 10.1002/ccd.23464

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  13 in total

1.  Long-Term Percutaneous Coronary Intervention Outcomes of Patients with Chronic Kidney Disease in the Era of Second-Generation Drug-Eluting Stents.

Authors:  Wojciech Wańha; Damian Kawecki; Tomasz Roleder; Aleksandra Pluta; Kamil Marcinkiewicz; Beata Morawiec; Janusz Dola; Sylwia Gładysz; Tomasz Pawłowski; Grzegorz Smolka; Andrzej Ochała; Ewa Nowalany-Kozielska; Wojciech Wojakowski
Journal:  Cardiorenal Med       Date:  2016-12-09       Impact factor: 2.041

2.  Targeting STUB1-tissue factor axis normalizes hyperthrombotic uremic phenotype without increasing bleeding risk.

Authors:  Moshe Shashar; Mostafa E Belghasem; Shinobu Matsuura; Joshua Walker; Sean Richards; Faisal Alousi; Keshab Rijal; Vijaya B Kolachalama; Mercedes Balcells; Minami Odagi; Kazuo Nagasawa; Joel M Henderson; Amitabh Gautam; Richard Rushmore; Jean Francis; Daniel Kirchhofer; Kumaran Kolandaivelu; David H Sherr; Elazer R Edelman; Katya Ravid; Vipul C Chitalia
Journal:  Sci Transl Med       Date:  2017-11-22       Impact factor: 17.956

Review 3.  Percutaneous coronary interventions and antiplatelet therapy in renal transplant recipients.

Authors:  Francesco Summaria; Maria Benedetta Giannico; Giovanni Paolo Talarico; Roberto Patrizi
Journal:  Ther Adv Cardiovasc Dis       Date:  2015-12-16

4.  Outcomes with prolonged clopidogrel therapy after coronary stenting in patients with chronic kidney disease.

Authors:  Omar K Siddiqi; Kyle J Smoot; Alyssa B Dufour; Kelly Cho; Melissa Young; David R Gagnon; Samantha Ly; Sara Temiyasathit; David P Faxon; J Michael Gaziano; Scott Kinlay
Journal:  Heart       Date:  2015-07-24       Impact factor: 5.994

Review 5.  A focused review on optimal coronary revascularisation in patients with chronic kidney disease: Coronary revascularisation in kidney disease.

Authors:  Andie H Djohan; Ching-Hui Sia; Joshua Ping-Yun Loh
Journal:  AsiaIntervention       Date:  2019-02-20

Review 6.  Thrombosis in the uremic milieu--emerging role of "thrombolome".

Authors:  Moshe Shashar; Jean Francis; Vipul Chitalia
Journal:  Semin Dial       Date:  2014-06-24       Impact factor: 3.455

Review 7.  Coronary artery disease in patients with chronic kidney disease: a clinical update.

Authors:  Qiangjun Cai; Venkata K Mukku; Masood Ahmad
Journal:  Curr Cardiol Rev       Date:  2013-11

8.  The Impact of Admission Serum Creatinine Derived Estimated Glomerular Filtration Rate on Major Adverse Cardiac Events in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention.

Authors:  Mahmut Uluganyan; Gurkan Karaca; Turker Kemal Ulutas; Ahmet Ekmekci; Eyup Tusun; Ahmet Murat; Bayram Koroglu; Huseyin Uyarel; Nijad Bakhshaliyev; Mehmet Eren
Journal:  J Clin Med Res       Date:  2016-02-27

9.  Differential Clinical Outcomes Between Angiographic Complete Versus Incomplete Coronary Revascularization, According to the Presence of Chronic Kidney Disease in the Drug-Eluting Stent Era.

Authors:  Jihoon Kim; Joo Myung Lee; Ki Hong Choi; Tae-Min Rhee; Doyeon Hwang; Jonghanne Park; Chul Ahn; Taek Kyu Park; Jeong Hoon Yang; Young Bin Song; Jin-Ho Choi; Joo-Yong Hahn; Seung-Hyuk Choi; Hyeon-Cheol Gwon
Journal:  J Am Heart Assoc       Date:  2018-02-15       Impact factor: 5.501

10.  Impact of early (3 months) dual antiplatelet treatment interruption prior to renal transplantation in patients with second-generation DES on perioperative stent thrombosis and MACEs.

Authors:  Ali Doğan; Emrah Özdemir; Serkan Kahraman; Tayfun Açıl; Yelda Saltan; Nuri Kurtoğlu
Journal:  Anatol J Cardiol       Date:  2017-12       Impact factor: 1.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.